Evaluation of a trial of syringe vending machines in Canberra, ACT, Australia

Embed Doc
Copy Link
Readcast
Collections

CommentGo Back

Download

iinnaassssoocciiaattiioonnwwiitthhDDaavviiddMMccDDoonnaalldd,,SSoocciiaallRReesseeaarrcchh&&EEvvaalluuaattiioonnPPttyyLLttdd

A A CCTTSSyyrriinnggee V VeennddiinnggMMaacchhiinneessTTrriiaall22000055 – –22000066

FFiinnaallrreeppoorrttbbyyDDaavviiddMMccDDoonnaalldd

1100AApprriill22000077

ACT Health SVM trialFinal reportPage ii

ACT Health SVM trialFinal reportPage iii

Contents

Acknowledgements........................................................................................................vThe ACT Syringe Vending Machine Trial...................................................................11. In brief ….................................................................................................................1 2. What do we already know about syringe vending machines?................................3 3. What was the Canberra SVM trial?.........................................................................5 4. Has access to sterile injecting equipment changed following the introduction of SVMs?......................................................................................................................7

4.1 What were the patterns of usage of the syringe vending machine?.............7Evaluation findings..................................................................................................94.2 How did providing SVMs impact on the other NSP outlets?......................10Evaluation findings................................................................................................11

5. Who is using the syringe vending machines?.......................................................12

5.1 What are the demographics of the SVM clients?.........................................125.2 Who uses the SVMs?......................................................................................135.3 What are the patterns of drug use among SVM clients?............................145.4 What are SVM clients’ patterns of access to sterile injecting equipment?15Evaluation findings................................................................................................18

6. Has the introduction of SVMs had any impact on needle sharing?.....................19

Evaluation findings................................................................................................19

7. In what ways do SVMs add to the role of the existing Needle and Syringe Program outlets?...................................................................................................20

7.1 Vending machine sales....................................................................................207.2 Why did the clients use the vending machines rather than other outlets?20Evaluation findings................................................................................................21

8.

Has the incidence of unsafe disposal of needles and syringes changed following the introduction of SVMs?

..........................................22

8.1 Was injecting equipment discarded in the vicinity of the SVMs?...............228.2 Were the disposal bins adjacent to the SVMs used?...................................248.3 What were the clients’ and other stakeholders’ views on discardedequipment?.............................................................................................................24Evaluation findings................................................................................................25

9. Are there any other products that clients believe should be available from theSVMs, and what are their views on the $2 charge?.............................................26

9.1 What views were expressed about the Fitpack contents?...........................269.2 What views were expressed about the cost of the Fitpacks?........................27

of 00

Leave a Comment